Advertisement

Topics

BioMarin Submits Pegvaliase Biologics License Application (BLA) to the U.S. ...

09:10 EDT 30 Jun 2017 | BioMedReports - Blog

"We believe that pegvaliase offers the promise of an important new treatment option for those adult patients with PKU unable to manage their condition with

Read more...

Original Article: BioMarin Submits Pegvaliase Biologics License Application (BLA) to the U.S. ...

NEXT ARTICLE

More From BioPortfolio on "BioMarin Submits Pegvaliase Biologics License Application (BLA) to the U.S. ..."

Advertisement
Quick Search
Advertisement
Advertisement